FAO AGRIS - International System for Agricultural Science and Technology

Secondary School Madrasas in Bangladesh : Incidence, Quality, and Implications for Reform

2010

World Bank


Bibliographic information
Publisher
Washington, DC
Other Subjects
Intervention; Local industry; Return on assets; Business environment; Business sector; Private pharmacies; Drug control; R&d; International standards; Technical training; Buyers; Sites; Technical standards; Multinational; Trade balance; Profit margin; Commodity; Market share; Drug prices; Registration process; Warehouse; Global marketplace; Export market; Expansion; Suppliers; Physical location; Open market; Active ingredients; Pharmaceutical patents; Currency; Inventory; Foreign company; Capital stock; Exporters; Import costs; Expenditures; International competitiveness; Bioequivalence; Capsules; Sale; Capability; Finances; Portfolio; Finished product; Inventory management; Drug testing; Lack of competition; Wholesalers; Counterfeit drugs; Drug stability; Domestic manufacturers; Price controls; Pharmaceutical sector; Ndp; Pharmaceutical manufacturing; Patent extensions; Raids; Return; Investing; International development; Functionality; Competitive advantage; Herbal medicines; Patent act; Procurement; Essential drugs; Export growth; Pharmaceutical production; Competitiveness; Profit margins; Trademark; Pharmacists; Substitute; Registration fees; Product information; Transparency; Distribution channel; Capabilities; International finance; Licensing; Generic drugs; Regulatory environments; Technical expertise; Global standards; Human development; Pharmacy; Drug approvals; International markets; Local market; Business opportunity; Manufacturer; Outsourcing; Result; Stock exchanges; Technical knowledge; Private sector firms; Sale of stock; Middlemen; Foreign markets; Mergers; Multinational corporation; Government policy; Turnover; Global trade; Intellectual property protection; Intellectual property; Total sales; End user; Marketplace; Antihistamines; Supply chain; International market; Global market; Brand name; Bank financing; Trademarks; Access to pharmaceuticals; Pharmaceutical quality; Party; Export markets; Pharmaceutical manufacturers; Foreign companies; Mnc; Human resource; Regulatory environment; World trade; Budget allocation; Registration fee; Generic products; Exporter; Public market; Investment financing; Inspections; Government finances; License; Pharmaceuticals; Investment capital; Technology transfers; Certificate; Foreign direct investment; Dosages; Company; Consumer market; International economics; Value chain; Domestic market; Regulatory structure; Tax; Licenses; No objection certificate; Pharmaceutical
License
Bangladesh development series paper;no. 27http://creativecommons.org/licenses/by/3.0/igo/CC BY 3.0 IGO
Source
Bangladesh development series paper;no. 27

2014-09-15
AGRIS AP
Data Provider

This bibliographic record has been provided by World Bank

Discover this data provider's collection in AGRIS

Lookup at Google Scholar
If you notice any incorrect information relating to this record, please contact us at [email protected]